Rubicon Overview
Rubicon Genomics is a leader in the development and commercialization of pre-analytical processes to improve the performance and capabilities of analytical platforms for research and clinical testing.
A privately held company located in Ann Arbor, Michigan, Rubicon was founded in May, 2000. Our core competency is the creation of families of molecular biology tools that enable more genetic, epigenetic, and expression data to be collected from patient samples of any size or condition.
Rubicon kits, services, partnerships, and licenses have enabled the discovery of many novel biomarkers and disease genes, and our technologies and products are protected by over 25 patent applications. Our customers include the largest pharmaceutical, biotechnology, and academic institutions in the world. Currently we have the fastest growing number of products and number of customers in the rapidly-expanding pre-analytical kit market.